首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1742873

生物库设备的全球市场

Biobanking Equipment

出版日期: 2025年06月06日 | 出版商:

Global Industry Analysts, Inc. | 英文 376 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球生物银行设备市场规模将达到 446 亿美元

全球生物样本库设备市场规模预计在2024年为380亿美元，预计2030年将达到446亿美元，2024年至2030年的复合年增长率为2.7%。设备是本报告分析的细分市场之一，预计其复合年增长率为3.9%，到分析期结束时将达到189亿美元。耗材细分市场在整个分析期间的复合年增长率预计为1.7%。

美国市场规模估计为 104 亿美元，中国市场预计复合年增长率为 5.3%

美国生物样本库设备市场规模预计2024年达到104亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到87亿美元，在2024-2030年的分析期间内，复合年增长率为5.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为0.9%和2.1%。在欧洲，预计德国市场的复合年增长率为1.5%。

全球生物银行设备市场－主要趋势与驱动因素摘要

为什么生物库设备成为精准医疗、生物医学研究和纵向生物样本完整性的核心？

生物样本库设备能够对组织、血液、DNA和细胞培养物等生物样本进行标准化、高完整性的存储，构成现代生物样本储存的基础设施基础。随着生物样本库规模的扩大及其策略意义的提升，尤其是在基因组学、肿瘤学、再生医学和临床试验领域，对可靠、扩充性且合规的生物银行系统的需求日益增长。冷冻库、冷藏柜、低温储存槽、样本管理软体和自动化处理系统共同确保了不同类型和储存期检体的可追溯性、可行性和品管。

群体规模生物样本库和多中心合作研究的激增，提升了生物样本库仪器在纵向研究、产生真实世界证据和支持个人化治疗模式的重要性。这些系统能够在严格控制的温度、湿度和无菌条件下安全储存和快速检索生物样本，这对于分子诊断、生物标记检验和治疗方法发现等下游应用至关重要。随着生命科学研发日益以资料主导，检体完整性和元资料准确性正成为实现可重复性和转化相关性的基础。

随着精准医疗和全球健康监测的兴起，生物样本库不再是孤立的资源库，而是融入研究、临床和商业工作流程的策略资产。生物样本库设备如今必须满足营运效率要求，并符合 ISO 20387、FDA CFR 21 第 11 部分和 GxP 等指南的监管要求。这种动态加剧了学术、政府和私人生物样本库对技术先进、审核且面向未来的仪器解决方案的需求。

自动化、低温运输创新和数位整合如何增强生物库仪器能力？

自动化正在改变生物样本库的业务，减少人工错误，提高处理量，并实现全天候访问海量样本库存。机器人储存和搜寻系统、自动贴标以及基于条码/RFID 的追踪技术，最大限度地减少了样本的差异性，并确保了样本的精准定位。这些创新技术在优化占地面积的同时，保持了超低温稳定性，支援在垂直或模组化系统中进行高密度储存。自动化在生物製药公司赞助的临床试验和大型队列研究中尤其重要，因为快速、无错误的处理至关重要。

低温储存技术的进步使设备更加可靠、节能。超低温冰箱（ULT）通常在-80°C下运作，现在采用低全球暖化潜势冷媒、节能压缩机和即时温度监控。用于长期储存干细胞、胚胎和RNA样本的液态氮储存槽现在配备了真空隔热板、远端监控系统和故障安全备用模组，以确保在断电或系统故障时不间断储存。

数位化整合助力实现全面的生物样本生命週期管理。实验室资讯管理系统 (LIMS)、云端基础仪表板和物联网感测器嵌入仪器，用于追踪样本元元资料、监测仪器健康状况并自动化审核追踪。与电子实验记录本 (ELN)、临床资料库和区块链平台的整合正在成为确保资料来源和增强跨站点协作的解决方案。随着互通性和数据完整性成为关键差异化因素，生物样本库仪器正在发展成为互联平台，将实体样本与数位生态系统即时连接。

哪些最终用户细分、区域投资和采购模式正在推动生物银行设备市场扩张？

学术研究机构、製药公司、医院生物样本库以及政府主导的人口研究是生物样本库设备的主要终端使用者。製药和生物技术公司正在投资私人生物样本库，以支援药物研发、伴随诊断和生物标记主导的临床开发。受託研究机构(CRO) 也在扩展其低温运输能力，以满足外包临床试验的生物样本储存和物流需求。

由于美国国立卫生研究院 (NIH) 支持的生物样本库网路、基因组学联盟和精准医疗计画的普及，北美在全球市场处于领先地位。欧洲紧随其后，这得益于 GDPR 和 ISO 标准下的监管协调以及产学合作的不断加强。亚太地区已成为高成长地区，中国、日本、韩国和印度等国家正在投资国家生物银行基础设施、基因组监测和转化医学平台。这些发展得到了公共资金、私人投资以及地方政府在医疗数位化和生物医学创新方面的授权的支持。

筹资策略正在演变，倾向于整合软体、服务协议和合规性支援的整合仪器套件。买家越来越重视那些具备扩充性、远距离诊断以及与更广泛的实验室IT生态系统相容的仪器。租赁模式、仪器即服务以及多年期服务合约在资源受限的实验室和新兴生物技术公司中越来越受欢迎，这使得他们能够在无需大量前期资本支出的情况下扩展其生物银行能力。

哪些因素推动了生物银行设备市场的成长？

随着生物样本储存对现代生物医学研究、治疗开发和个人化医疗服务至关重要，生物样本库设备市场正在不断扩大。设备创新正在为日益广泛的生物材料和使用案例提供可靠、扩充性且数位化互联的储存。

主要成长动力包括大型生物样本库专案的兴起、自动化和智慧监控系统的整合、对合规基础设施的需求不断增长，以及生命科学研发领域生物样本主导洞察的价值不断提升。区域性投资在人口健康、精准肿瘤学和感染疾病监测方面的成长势头进一步推动了市场发展。

随着生物库从被动式储存单元转变为策略性资料生成中心，生物库设备能否成为下一代精准医疗生态系统中生物样本、真实世界资料和数位健康平台融合的技术节点？

部分

产品类型（仪器、消耗品、软体、服务）、应用（再生医学、药物发现和临床研究、诊断）、最终用途（製药、生物库、医院、受託研究机构、其他最终用途）

受访企业范例（共34家）

Azenta Life Sciences
Becton, Dickinson and Company（BD）
Bio-Techne Corporation
Brooks Automation, Inc.
Greiner Bio-One International GmbH
Haier Biomedical
Hamilton Company
Harvard Bioscience, Inc.
Izon Science Limited
Lonza Group AG
Merck KGaA
Orcella Instruments
Panasonic Healthcare Holdings Co., Ltd.
PHC Holdings Corporation（PHCbi）
Promega Corporation
Qiagen NV
Sartorius AG
Standard BioTools Inc.
Stemcell Technologies Inc.
Tecan Group Ltd.

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

The global market for Biobanking Equipment estimated at US$38.0 Billion in the year 2024, is expected to reach US$44.6 Billion by 2030, growing at a CAGR of 2.7% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$18.9 Billion by the end of the analysis period. Growth in the Consumables segment is estimated at 1.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$10.4 Billion While China is Forecast to Grow at 5.3% CAGR

The Biobanking Equipment market in the U.S. is estimated at US$10.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$8.7 Billion by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Biobanking Equipment Market - Key Trends & Drivers Summarized

Why Is Biobanking Equipment Becoming Central to Precision Medicine, Biomedical Research, and Long-Term Biospecimen Integrity?

Biobanking equipment forms the infrastructure backbone of modern biospecimen preservation, enabling standardized, high-integrity storage of biological materials such as tissues, blood, DNA, and cell cultures. As biorepositories grow in size and strategic relevance, especially within genomics, oncology, regenerative medicine, and clinical trials, the demand for reliable, scalable, and compliant biobanking systems is intensifying. Freezers, refrigerators, cryogenic tanks, sample management software, and automated handling systems collectively ensure traceability, viability, and quality control across diverse specimen types and storage durations.

The proliferation of population-scale biobanks and multi-center research collaborations has elevated the importance of biobanking equipment in supporting longitudinal studies, real-world evidence generation, and personalized treatment models. These systems enable the secure archiving and rapid retrieval of biospecimens under tightly controlled temperature, humidity, and sterility conditions-critical for downstream applications in molecular diagnostics, biomarker validation, and therapeutic discovery. As life science R&D becomes increasingly data-driven, specimen integrity and metadata accuracy are emerging as foundational enablers of reproducibility and translational relevance.

Amid the rise of precision medicine and global health surveillance, biobanks are no longer isolated storage units but strategic assets integrated into research, clinical, and commercial workflows. Biobanking equipment must now meet not only operational efficiency requirements but also regulatory expectations under guidelines such as ISO 20387, FDA CFR 21 Part 11, and GxP. These dynamics are reinforcing demand for technologically advanced, auditable, and future-ready equipment solutions across academic, government, and private sector biorepositories.

How Are Automation, Cold Chain Innovation, and Digital Integration Enhancing Biobanking Equipment Functionality?

Automation is transforming biobank operations by reducing manual handling errors, increasing throughput, and enabling 24/7 access to high-volume sample inventories. Robotic storage and retrieval systems, automated labeling, and barcode/RFID-based tracking are minimizing variability and ensuring precise sample localization. These innovations support high-density storage in vertical or modular systems, optimizing footprint while maintaining ultra-low temperature stability. Automation is particularly vital in biopharma-sponsored trials and large-scale cohort studies where rapid, error-free processing is essential.

Advancements in cold storage technologies are further enhancing equipment reliability and energy efficiency. Ultra-low temperature freezers (ULTs), typically operating at -80°C, are now being designed with low-GWP refrigerants, energy-saving compressors, and real-time temperature monitoring. Liquid nitrogen-based cryogenic tanks-used for long-term preservation of stem cells, embryos, and RNA samples-are incorporating vacuum-insulated panels, remote monitoring systems, and fail-safe backup modules to ensure uninterrupted storage during power outages or system failures.

Digital integration is enabling comprehensive biospecimen lifecycle management. Laboratory information management systems (LIMS), cloud-based dashboards, and IoT-enabled sensors are being embedded into equipment to track sample metadata, monitor equipment health, and automate audit trails. Integration with ELNs, clinical databases, and blockchain platforms is emerging as a solution to secure data provenance and enhance cross-institutional collaboration. As interoperability and data integrity become critical differentiators, biobanking equipment is evolving into connected platforms that link physical samples with digital ecosystems in real time.

Which End-User Segments, Regional Investments, and Procurement Models Are Driving Market Expansion for Biobanking Equipment?

Academic research institutions, pharmaceutical companies, hospital-based biobanks, and government-led population studies represent the primary end-user base for biobanking equipment. Pharmaceutical and biotech firms are investing in private biorepositories to support drug discovery, companion diagnostics, and biomarker-driven clinical development. Contract research organizations (CROs) are also expanding cold-chain capabilities to meet the biospecimen storage and logistics needs of outsourced clinical trials.

North America leads the global market, anchored by NIH-supported biobank networks, genomics consortia, and widespread adoption of precision medicine programs. Europe follows closely, driven by regulatory harmonization under GDPR and ISO standards, alongside growing academic-industry partnerships. Asia-Pacific is emerging as a high-growth region with countries like China, Japan, South Korea, and India investing in national biobanking infrastructure, genomic surveillance, and translational health platforms. These developments are supported by public funding, private investments, and regional government mandates around healthcare digitization and biomedical innovation.

Procurement strategies are evolving to favor integrated equipment suites bundled with software, service contracts, and compliance support. Buyers are increasingly prioritizing equipment that offers scalability, remote diagnostics, and compatibility with broader laboratory IT ecosystems. Rental models, equipment-as-a-service offerings, and multi-year service agreements are gaining traction among resource-constrained labs and startup biotechs, allowing them to scale biobanking capabilities without high upfront capital expenditure.

What Are the Factors Driving Growth in the Biobanking Equipment Market?

The biobanking equipment market is expanding as biospecimen preservation becomes mission-critical to modern biomedical research, therapeutic development, and personalized healthcare delivery. Equipment innovation is enabling high-integrity, scalable, and digitally connected storage across a growing spectrum of biological materials and use cases.

Key growth drivers include the rise of large-scale biobanking initiatives, integration of automation and smart monitoring systems, increasing demand for regulatory-compliant infrastructure, and the growing value of biospecimen-driven insights in life sciences R&D. Regional investments in population health, precision oncology, and infectious disease surveillance are further amplifying market momentum.

As biobanks transition from passive storage units to strategic data-generating hubs, could biobanking equipment become the technological nexus enabling the convergence of biological samples, real-world data, and digital health platforms in next-generation precision medicine ecosystems?

SCOPE OF STUDY:

The report analyzes the Biobanking Equipment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Equipment, Consumables, Software, Services); Application (Regenerative Medicine, Drug Discovery & Clinical Research, Diagnostics); End-Use (Pharmaceutical, Biobanks, Hospitals, Contract Research Organizations, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

Azenta Life Sciences
Becton, Dickinson and Company (BD)
Bio-Techne Corporation
Brooks Automation, Inc.
Greiner Bio-One International GmbH
Haier Biomedical
Hamilton Company
Harvard Bioscience, Inc.
Izon Science Limited
Lonza Group AG
Merck KGaA
Orcella Instruments
Panasonic Healthcare Holdings Co., Ltd.
PHC Holdings Corporation (PHCbi)
Promega Corporation
Qiagen N.V.
Sartorius AG
Standard BioTools Inc.
Stemcell Technologies Inc.
Tecan Group Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Biobanking Equipment - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Demand for Biospecimen Preservation in Genomic and Clinical Research Throws the Spotlight on Biobanking Equipment
- Growth in Personalized Medicine and Cancer Biorepositories Spurs Investment in Long-Term Cryogenic Storage
- OEM Innovation in Ultra-Low Temperature Freezers and Automated Sample Handling Enhances Sample Integrity
- Expansion of Cell and Gene Therapy Trials Supports Need for High-Capacity, GMP-Compliant Storage Systems
- Integration of RFID, Barcode, and Biometric Access Controls Enhances Inventory Accuracy and Data Traceability
- Growth in Population-Based Biobanks and Epidemiological Studies Fuels Demand for Scalable Storage Infrastructure
- Rising Focus on Quality Control and Audit Readiness Drives Demand for Temperature Mapping and Alarm Systems
- Use in Forensics, Transplant, and Regenerative Medicine Expands Biobank Application Scope
- Adoption of Green Cooling Technologies and Energy-Efficient ULT Freezers Aligns With Sustainability Targets
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Biobanking Equipment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Biobanking Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Biobanking Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Biobanking Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 22: World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 28: World 15-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 31: World 15-Year Perspective for Biobanks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 34: World 15-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Drug Discovery & Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Drug Discovery & Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 37: World 15-Year Perspective for Drug Discovery & Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 39: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 40: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 41: USA Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 43: USA 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: USA Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 46: USA 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 47: USA Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: USA Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 49: USA 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
CANADA
- TABLE 50: Canada Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 52: Canada 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 53: Canada Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 55: Canada 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 56: Canada Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Canada Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 58: Canada 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
JAPAN
- Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 59: Japan Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: Japan Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 61: Japan 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 62: Japan Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: Japan Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 64: Japan 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 65: Japan Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: Japan Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 67: Japan 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
CHINA
- Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 68: China Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 69: China Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 70: China 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 71: China Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: China Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 73: China 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 74: China Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: China Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 76: China 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
EUROPE
- Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 77: Europe Recent Past, Current & Future Analysis for Biobanking Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Biobanking Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 79: Europe 15-Year Perspective for Biobanking Equipment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 80: Europe Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: Europe Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 82: Europe 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 83: Europe Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Europe Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 85: Europe 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 86: Europe Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: Europe Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 88: Europe 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
FRANCE
- Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 89: France Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: France Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 91: France 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 92: France Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: France Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 94: France 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 95: France Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 96: France Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 97: France 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
GERMANY
- Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 98: Germany Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 99: Germany Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 100: Germany 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 101: Germany Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 102: Germany Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 103: Germany 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 104: Germany Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 105: Germany Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 106: Germany 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
ITALY
- TABLE 107: Italy Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 108: Italy Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 109: Italy 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 110: Italy Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 111: Italy Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 112: Italy 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 113: Italy Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 114: Italy Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 115: Italy 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
UNITED KINGDOM
- Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 116: UK Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 117: UK Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 118: UK 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 119: UK Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 120: UK Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 121: UK 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 122: UK Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 123: UK Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 124: UK 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
SPAIN
- TABLE 125: Spain Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 126: Spain Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 127: Spain 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 128: Spain Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 129: Spain Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 130: Spain 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 131: Spain Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 132: Spain Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 133: Spain 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
RUSSIA
- TABLE 134: Russia Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 135: Russia Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 136: Russia 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 137: Russia Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 138: Russia Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 139: Russia 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 140: Russia Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 141: Russia Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 142: Russia 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
REST OF EUROPE
- TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 144: Rest of Europe Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 145: Rest of Europe 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 147: Rest of Europe Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 148: Rest of Europe 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 150: Rest of Europe Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 151: Rest of Europe 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
ASIA-PACIFIC
- Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 153: Asia-Pacific Historic Review for Biobanking Equipment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 154: Asia-Pacific 15-Year Perspective for Biobanking Equipment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 156: Asia-Pacific Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 157: Asia-Pacific 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 159: Asia-Pacific Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 160: Asia-Pacific 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 162: Asia-Pacific Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 163: Asia-Pacific 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
AUSTRALIA
- Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 164: Australia Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 165: Australia Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 166: Australia 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 167: Australia Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 168: Australia Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 169: Australia 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 170: Australia Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 171: Australia Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 172: Australia 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
INDIA
- Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 173: India Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 174: India Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 175: India 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 176: India Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 177: India Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 178: India 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 179: India Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 180: India Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 181: India 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
SOUTH KOREA
- TABLE 182: South Korea Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 183: South Korea Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 184: South Korea 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 185: South Korea Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 186: South Korea Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 187: South Korea 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 188: South Korea Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 189: South Korea Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 190: South Korea 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 192: Rest of Asia-Pacific Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 195: Rest of Asia-Pacific Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 198: Rest of Asia-Pacific Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
LATIN AMERICA
- Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 200: Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 201: Latin America Historic Review for Biobanking Equipment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 202: Latin America 15-Year Perspective for Biobanking Equipment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 203: Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 204: Latin America Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 205: Latin America 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 206: Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 207: Latin America Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 208: Latin America 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 209: Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 210: Latin America Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 211: Latin America 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
ARGENTINA
- TABLE 212: Argentina Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 213: Argentina Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 214: Argentina 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 215: Argentina Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 216: Argentina Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 217: Argentina 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 218: Argentina Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 219: Argentina Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 220: Argentina 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
BRAZIL
- TABLE 221: Brazil Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 222: Brazil Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 223: Brazil 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 224: Brazil Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 225: Brazil Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 226: Brazil 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 227: Brazil Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 228: Brazil Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 229: Brazil 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
MEXICO
- TABLE 230: Mexico Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 231: Mexico Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 232: Mexico 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 233: Mexico Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 234: Mexico Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 235: Mexico 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 236: Mexico Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 237: Mexico Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 238: Mexico 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 240: Rest of Latin America Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 241: Rest of Latin America 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 243: Rest of Latin America Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 244: Rest of Latin America 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 246: Rest of Latin America Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 247: Rest of Latin America 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
MIDDLE EAST
- Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 248: Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 249: Middle East Historic Review for Biobanking Equipment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 250: Middle East 15-Year Perspective for Biobanking Equipment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 251: Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 252: Middle East Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 253: Middle East 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 254: Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 255: Middle East Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 256: Middle East 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 257: Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 258: Middle East Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 259: Middle East 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
IRAN
- TABLE 260: Iran Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 261: Iran Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 262: Iran 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 263: Iran Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 264: Iran Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 265: Iran 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 266: Iran Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 267: Iran Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 268: Iran 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
ISRAEL
- TABLE 269: Israel Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 270: Israel Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 271: Israel 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 272: Israel Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 273: Israel Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 274: Israel 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 275: Israel Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 276: Israel Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 277: Israel 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
SAUDI ARABIA
- TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 279: Saudi Arabia Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 280: Saudi Arabia 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 282: Saudi Arabia Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 283: Saudi Arabia 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 285: Saudi Arabia Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 286: Saudi Arabia 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 287: UAE Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 288: UAE Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 289: UAE 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 290: UAE Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 291: UAE Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 292: UAE 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 293: UAE Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 294: UAE Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 295: UAE 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 297: Rest of Middle East Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 298: Rest of Middle East 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 300: Rest of Middle East Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 301: Rest of Middle East 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 303: Rest of Middle East Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 304: Rest of Middle East 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030
AFRICA
- Biobanking Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 305: Africa Recent Past, Current & Future Analysis for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 306: Africa Historic Review for Biobanking Equipment by Product Type - Equipment, Consumables, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 307: Africa 15-Year Perspective for Biobanking Equipment by Product Type - Percentage Breakdown of Value Sales for Equipment, Consumables, Software and Services for the Years 2015, 2025 & 2030
- TABLE 308: Africa Recent Past, Current & Future Analysis for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 309: Africa Historic Review for Biobanking Equipment by End-Use - Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 310: Africa 15-Year Perspective for Biobanking Equipment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Contract Research Organizations, Other End-Uses, Pharmaceutical and Biobanks for the Years 2015, 2025 & 2030
- TABLE 311: Africa Recent Past, Current & Future Analysis for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 312: Africa Historic Review for Biobanking Equipment by Application - Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 313: Africa 15-Year Perspective for Biobanking Equipment by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Drug Discovery & Clinical Research and Diagnostics for the Years 2015, 2025 & 2030